COMMISSION IMPLEMENTING REGULATION (EU) 2025/839 of 5 May 2025 granting a Union authorisation for the biocidal product family ‘Oxivir Excel BPF’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ANNEX SUMMARY OF PRODUCT CHARACTERISTICS FOR A BIOCIDAL PRODUCT FAMILY

COMMISSION IMPLEMENTING REGULATION (EU) 2025/839 of 5 May 2025 granting a Union authorisation for the biocidal product family ‘Oxivir Excel BPF’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ANNEX SUMMARY OF PRODUCT CHARACTERISTICS FOR A BIOCIDAL PRODUCT FAMILYeu-regulation-2025-x-x-839